Form 4: Whitehawk Therapeutics Director Granted Significant Stock Options

Whitehawk Therapeutics, Inc. Director and 10% owner, Zhao Baiteng, was granted 40,006 stock options with an exercise price of $2.04, vesting by June 2026.

Summary

• Zhao Baiteng, a Director and 10% owner of Whitehawk Therapeutics, Inc. (WHWK), was granted 40,006 stock options.
• The stock options have an exercise price of $2.04 per share.
• The grant date for these options is June 17, 2025.
• The options are set to expire on June 17, 2035.
• One hundred percent (100%) of the shares subject to the option will vest on the earlier of June 12, 2026, or the day immediately prior to the next annual meeting of stockholders following the grant date.
• Vesting is contingent upon Zhao Baiteng continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable vesting date.
• Following this reported transaction, Zhao Baiteng beneficially owns 40,006 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The filing reports a standard stock option grant to a director, which is a positive sign of alignment between management and shareholder interests, but does not contain information that would significantly alter the company's financial outlook or operations.

Positives

• The grant of stock options to a director and 10% owner aligns their financial interests with those of the shareholders, incentivizing long-term company performance.
• The vesting schedule encourages continued service and commitment from a key stakeholder, promoting stability in leadership.

Risks

• The vesting of the stock options is conditional on the reporting person continuing to be a Service Provider; if service ceases before the vesting date, the options may be forfeited.

Future Outlook

The vesting schedule for the granted options indicates an intention to incentivize the director's continued service until at least June 12, 2026, or the next annual meeting, aligning their long-term commitment with the company's future performance.

Industry Context

Granting stock options to directors and key personnel is a common practice across various industries, including biotechnology and pharmaceuticals, to attract, retain, and motivate talent. This practice aligns the interests of company leadership with long-term shareholder value creation, particularly for growth-oriented companies like Whitehawk Therapeutics.

Comparison to Industry Standards

• Stock option grants are a standard component of executive and director compensation packages across industries, including biotech. The specific size of the grant (40,006 options) and the exercise price ($2.04) would typically be evaluated against peer companies of similar market capitalization, stage of development, and industry sector to determine if it is in line with, above, or below industry norms. Without specific comparable company data, a detailed assessment against industry benchmarks is not feasible.

Corporate Governance

Related Party Transactions

• The grant of stock options to Zhao Baiteng, a Director and 10% owner, constitutes a related party transaction as it involves compensation from the company to an insider.

Stakeholder Impact

• Shareholders: Potential for future dilution if options are exercised, but also increased alignment of the director's long-term financial interests with shareholder value creation.
• Management/Directors: Zhao Baiteng receives a significant equity incentive, which ties his personal financial success directly to the company's stock performance and encourages continued dedication.

Next Steps

• The granted options will vest on the earlier of June 12, 2026, or the day prior to the next annual meeting of stockholders, provided the director continues to serve.
• Upon vesting, the options can be exercised by the director at the specified exercise price until their expiration date of June 17, 2035.

Key Dates

Keywords

Whitehawk Therapeutics, WHWK, Stock Options, Form 4, Insider Transaction, Director Compensation, Equity Incentive Plan, Zhao Baiteng